In another study, PIP treatment prevented colon cancer by inducing Nrf2 antioxidants and inhibiting the NF-κB pathway in 1,2–Dimethylhydrazine-induced colon cancer [39]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.